The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …

The extracellular matrix (ECM) is a macromolecules network, in which the most abundant
molecule is collagen. This protein in triple helical conformation is highly resistant to …

Osteoarthritis (OA) is a chronic musculoskeletal disorder characterized by an imbalance
between (synthesis) and catabolism (degradation) in altered homeostasis of articular …

Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade proteins of the
extracellular matrix and the basement membrane. Thus, these enzymes regulate airway …

Simple Summary MMP-13 is an enzyme that can digest and disrupt the tissue structures
surrounding epithelial cells that line the surface of many internal organs, as well as the …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of mortality
globally and the risk of develo** lung cancer is six times greater in individuals with COPD …

Luminescence bioimaging and biosensing in the second near‐infrared (NIR‐II) spectral
window (1,000–1,700 nm wavelengths) is a newly emerging technique that is extensively …

The extracellular matrix (ECM) is a complex non-cellular three-dimensional macromolecular
network present within all tissues and organs, forming the foundation on which cells sit, and …

Targeted radionuclide theranostics is becoming more and more prominent in clinical
oncology. Currently, most nuclear medicine compounds researched for cancer theranostics …

Background Matrix metalloproteinases from macrophages are important intraplaque
components that play pivotal roles in plaque progression and regression. This study sought …